Science
Science at Ceregene »
Neurotrophic Factors »
Gene Delivery Technology »
Newsroom
05-27-09: Ceregene Presents Additional Clinical Data from Phase 2 Trial of CERE-120 for Parkinson's Disease»
11-26-08: Ceregene Announces
Clinical Data from Phase 2 Clinical Trial
of CERE-120 for Parkinson's Disease»
11-04-08: Ceregene Phase 2 Clinical Trial
for Alzheimer's Disease to be Funded by
$5.4 Million Grant from National Institutes
of Health »
Corporate Office:
9381 Judicial Drive, Suite 130
San Diego, CA 92121
T: 858-458-8800
F: 858-458-8801
© Ceregene. All rights reserved.
9381 Judicial Drive, Suite 130
San Diego, CA 92121
T: 858-458-8800
F: 858-458-8801
© Ceregene. All rights reserved.
